Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study

Seok Jin Kim, Jing Quan Lim, Yurike Laurensia, +13

Blood

The prognostic significance of tumor-associated stroma in invasive breast carcinoma

Soomin Ahn, Junhun Cho, Ji‐Youn Sung, +4

Tumor Biology

Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer

Sang Byung Bae, Hyun Deuk Cho, Mee‐Hye Oh, +9

Journal of Breast Cancer

Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas

Eun Yoon Cho, Kyeongmee Park, In‐Gu Do, +4

Modern Pathology

Tumor BiologyMedicineGastroenterologyPathologyTissue Microarray +9

Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability

Junhun Cho, Young Hwan Chang, You Jeong Heo, +6

ESMO Open

High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.

Seung Eun Lee, Yu Jin Kim, Mi Kwon, +7

PubMed

Mdm2 AmplificationCdk4 AmplificationTumoral PathologyMalignant DiseaseMedicine +11

Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability

Junhun Cho, Jeeyun Lee, Heejin Bang, +10

Oncotarget

Tumor BiologyCancer ImmunosurveillancePd-l1 ExpressionMedicineMicrosatellite Instability +13

Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression

Junhun Cho, Seok Jin Kim, Woong‐Yang Park, +6

Modern Pathology

Lymphoid NeoplasiaImmune ShiftAutoimmune DiseaseExtranodal Nk/t-cell LymphomaImmunology +9

Bridging genomics and phenomics of gastric carcinoma

Junhun Cho, Soomin Ahn, Dae‐Soon Son, +14

International Journal of Cancer

PathologyTumor BiologyTumor HeterogeneityHigh TmbMolecular Diagnostics +14

Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of <i>HAVCR2</i> mutations

Jiwon Koh, Insoon Jang, Seungchan Mun, +12

Blood Advances